How it works
A GHRH analogue that binds pituitary GHRH receptors and activates cAMP/PKA to study growth-hormone release.
CATALOG ITEM
CJC1295 DAC
Certificate of analysis (COA)
- Strength
- 5 mg
- Batch number on the certificate (Batch Number)
- CS-cwd5-0922
- Analysis date
Identifying details were hidden for privacy. The test results are shown as they appeared in the original report. For research use only.
CJC-1295 DAC: material identity and pack details
This entry is for CJC1295 DAC. The No DAC item and Ipamorelin blends are listed separately; the shared CJC name does not make them interchangeable. Compare the full name, labeled strength, vial count and certificate details before comparing pack options.
| Labeled strength | Units per pack |
|---|---|
| 5 mg | 10 vials |
Select a strength above to see its current pack price. These are catalog specifications, not instructions for use.
Reviewing the CJC1295 DAC COA
The certificate panel above follows the selected strength. Check the material name, strength, batch number and analysis date on the report. A certificate describes the tested sample and batch; it does not establish results for every pack or other batches.
When no certificate is available for the selected strength, the panel says so. The certificate library includes the available reports and a search by product or batch number.
What it is studied in
Studied in growth-hormone deficiency, body-composition changes, and excess visceral fat.
Key benefits
The GH/IGF-1 axis, growth-hormone secretion, body composition, and metabolism.
What sets it apart
A GHRH analogue, acting upstream on the pituitary.